Prosight Management, LP
- SEC CIK
- 0001617201
- 最新申報
- 2026/8/14
2024 年第 3 季持倉
持倉截至 2024/9/30，2024/11/14 申報。只含多頭部位，變化是跟 2024 年第 2 季比股數。
- 持股檔數
- 41
- 較 2024 年第 2 季 −5
- 總值
- $3.94 億
- 較 2024 年第 2 季 +$5,978 萬 (+17.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ADCTADC Therapeutics SA | SHS | 9,636,237 | $3,035 萬 | 7.7% | +66,237+0.7% | 加碼 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 1,028,843 | $2,962 萬 | 7.5% | −321,137−23.8% | 減碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 1,086,810 | $2,767 萬 | 7.0% | +286,810+35.9% | 加碼 | 歷史 |
| ABCLAbCellera Biologics Inc. | COM | 9,079,539 | $2,361 萬 | 6.0% | +6,726,906+285.9% | 加碼 | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 4,900,570 | $2,044 萬 | 5.2% | +547,870+12.6% | 加碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 1,721,512 | $1,987 萬 | 5.0% | −278,488−13.9% | 減碼 | 歷史 |
| STTKShattuck Labs, Inc. | COM | 5,678,726 | $1,982 萬 | 5.0% | +1,008,726+21.6% | 加碼 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 465,825 | $1,817 萬 | 4.6% | +151,025+48.0% | 加碼 | 歷史 |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 165,602 | $1,788 萬 | 4.5% | −4,398−2.6% | 減碼 | 歷史 |
| MCKMcKesson Corp | Stock | 35,822 | $1,771 萬 | 4.5% | +35,822 | 新進 | 歷史 |
| KURAKura Oncology, Inc. | COM | 705,109 | $1,378 萬 | 3.5% | +75,209+11.9% | 加碼 | 歷史 |
| SDGRSchrodinger, Inc. | COM | 700,000 | $1,299 萬 | 3.3% | +330,739+89.6% | 加碼 | 歷史 |
| ZYMEZymeworks Inc. | COM | 917,599 | $1,152 萬 | 2.9% | −262,401−22.2% | 減碼 | 歷史 |
| ACCDAccolade, Inc. | COM | 2,801,598 | $1,079 萬 | 2.7% | +1,312,073+88.1% | 加碼 | 歷史 |
| DXCMDexcom Inc | COM | 160,000 | $1,073 萬 | 2.7% | +110,683+224.4% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 554,103 | $1,067 萬 | 2.7% | +2,559+0.5% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 370,000 | $1,055 萬 | 2.7% | +45,000+13.8% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 192,700 | $1,017 萬 | 2.6% | −37,300−16.2% | 減碼 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 205,000 | $931.3 萬 | 2.4% | +205,000 | 新進 | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 483,467 | $808.8 萬 | 2.1% | +196,541+68.5% | 加碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 62,000 | $714.4 萬 | 1.8% | +35,000+129.6% | 加碼 | 歷史 |
| ERASErasca, Inc. | COM | 1,984,010 | $541.6 萬 | 1.4% | −765,990−27.9% | 減碼 | 歷史 |
| HAEHaemonetics Corp | COM | 65,000 | $522.5 萬 | 1.3% | +65,000 | 新進 | 歷史 |
| LIVNLivaNova PLC | SHS | 90,000 | $472.9 萬 | 1.2% | +90,000 | 新進 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 410,830 | $443.7 萬 | 1.1% | −89,170−17.8% | 減碼 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 47,100 | $435.7 萬 | 1.1% | +47,100 | 新進 | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 137,614 | $417.0 萬 | 1.1% | +70,153+104.0% | 加碼 | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 3,022,109 | $356.6 萬 | 0.9% | +3,022,109 | 新進 | 歷史 |
| SGHTSight Sciences, Inc. | COM | 531,222 | $334.7 萬 | 0.8% | +531,222 | 新進 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 48,000 | $303.9 萬 | 0.8% | −67,000−58.3% | 減碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 159,369 | $294.4 萬 | 0.7% | +159,369 | 新進 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 130,000 | $268.2 萬 | 0.7% | +130,000 | 新進 | 歷史 |
| MURAMural Oncology plc | ORD SHS | 570,620 | $178.6 萬 | 0.5% | +95,162+20.0% | 加碼 | 歷史 |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 208,200 | $173.0 萬 | 0.4% | +208,200 | 新進 | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 2,206,505 | $158.0 萬 | 0.4% | −281,913−11.3% | 減碼 | 歷史 |
| RNTXRein Therapeutics, Inc. | COM NEW | 372,157 | $131.7 萬 | 0.3% | +107,157+40.4% | 加碼 | 歷史 |
| SEMSelect Medical Holdings Corp | COM | 26,065 | $90.9 萬 | 0.2% | +26,065 | 新進 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 729,208 | $86.0 萬 | 0.2% | −345,792−32.2% | 減碼 | 歷史 |
| IMNMImmunome Inc. | COM | 39,135 | $57.2 萬 | 0.1% | −25,865−39.8% | 減碼 | 歷史 |
| IMRXImmuneering Corp | CLASS A COM | 190,000 | $47.3 萬 | 0.1% | −360,000−65.5% | 減碼 | 歷史 |
| ACHCAcadia Healthcare Company, Inc. | COM | 5,666 | $35.9 萬 | 0.1% | +5,666 | 新進 | 歷史 |
選擇權（4 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| iShares Tr464287955 | PUT | $640.6 萬 | – |
| Cassava Sciences Inc14817C957 | PUT | $438.2 萬 | – |
| Corvel Corp221006959 | PUT | $91.5 萬 | – |
| Shattuck Labs Inc82024L953 | PUT | – | $30.3 萬 |
2024 年第 2 季之後清倉（17 檔）
2024 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 2 季股數 | 2024 年第 2 季市值 | 2024 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| KELYAKelly Services Inc | CL A | 492,340 | $1,054 萬 | 3.2% | 歷史 |
| ALKSAlkermes plc. | SHS | 275,000 | $662.8 萬 | 2.0% | 歷史 |
| KIDSOrthopediatrics Corp | COM | 200,216 | $575.8 萬 | 1.7% | 歷史 |
| OPCHOption Care Health, Inc. | COM NEW | 205,000 | $567.9 萬 | 1.7% | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 385,000 | $251.0 萬 | 0.8% | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 398,700 | $246.4 萬 | 0.7% | 歷史 |
| CVSCVS Health Corp | Stock | 40,000 | $236.2 萬 | 0.7% | 歷史 |
| MDTMedtronic plc | Stock | 30,000 | $236.1 萬 | 0.7% | 歷史 |
| INSPInspire Medical Systems, Inc. | COM | 14,000 | $187.4 萬 | 0.6% | 歷史 |
| FNAParagon 28, Inc. | COM | 261,400 | $178.8 萬 | 0.5% | 歷史 |
| UHSUniversal Health Services Inc | CL B | 9,373 | $173.3 萬 | 0.5% | 歷史 |
| PRVAPrivia Health Group, Inc. | COM | 96,065 | $167.0 萬 | 0.5% | 歷史 |
| ADUSAddus HomeCare Corp | COM | 12,500 | $145.1 萬 | 0.4% | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 59,542 | $102.9 萬 | 0.3% | 歷史 |
| TXG10x Genomics, Inc. | CL A COM | 49,021 | $95.3 萬 | 0.3% | 歷史 |
| BMEABiomea Fusion, Inc. | COM | 124,377 | $56.0 萬 | 0.2% | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 56,080 | $3.36 萬 | <0.1% | 歷史 |